KD-026

N/A

Report date: 2022/08/19 20:00:31
NME

Base Information

Drug NameKD-026
Drug Alias NameSLx-4090KD-026KD026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsHypertriglyceridemiaHyperlipidemiasDiabetes Mellitus, Type 2 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKadmon Corporation Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterResponse Pharma Pvt LtdKadmon Corporation Llc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHyperlipidemiasDiabetes Mellitus, Type 2 +[4] 

Other Information

ATC CodeN/A
Related LinksN/A